Skip to content

Apotheek Vanheusden

Active
Public limited companyfounded 1989active for 36 yearsMarkt 12, 3740 Bilzen-Hoeselt, BelgiumKBO/BCE: BE 0439.111.575
Summary

Apotheek Vanheusden has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €294,757 and a net result of €391,389. Equity is growing by about 3.4% per year across the filed financial years. Its solvency ranks better than 24% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€2.1mtotal assets 2025
Staff
1.7 FTE
Equity
€294,757
Profit
€391,389
Turnover not published (abbreviated or micro format)
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
VANHEUSDEN · 100%
2025 accounts 52 days early2 of 5 deeds summarised
Why 88raises riskEquity €294,757 (13.9% of total assets)Sector: Retail trade (NACE 47)lowers riskFounded in 1989Size: 1.7 FTE, total assets €2.1mShow the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 47% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 39+3
equity 13.9% of total assets
Liquidity 33+9
short-term debt 76.9% · cash 19.7%
Profitability 92+1
return on assets 18.5%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2%lowest value 12-2024: 0.2%● unchanged vs 11-2024lowest value 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.3%▲ +0.1 percentage points vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.3%▼ -0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.2%▼ -0.1 percentage points vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.0, compared with 1.01 in 2024, below the usual 1.5; short-term debt: 76.9% and cash: 19.7% of total assets), and 86.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 30% on solvency, 30% on liquidity, 86% on profitability and 41% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €294,757 (13.9% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1989
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 1.7 FTE, total assets €2.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 12661 sector peers (2025).
NBB · sector comparison
Position among 12661 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
52 days early
2024
13 days early
2023
26 days early
2022
18 days late
2021
47 days early
2020
46 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 20 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Permanent representative: VANHEUSDEN DirkGazette deed

Key points

  • Positive: Among the best 5% on net resultsector median €27,731 · 12,651 companies €391,389 View
  • Positive: 8 profitable years in a rowprofit 2025: €391,389 8 years View
  • Controlled by VANHEUSDEN 100% View

By topic

Financials

Financial year
2025
Total assets
€2.1m
Profit
€391,389
Solvency
13.9%
Total assets▼ 19.3%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
VANHEUSDEN · 100%
  • VANHEUSDEN Dirk FerdinandChair
  • DENCKENS Hilde Irène Emiel MariaDirector
Go to Board & ownership

Timeline

Events
41
Since
1991
Next accounts
by 31-07-2027
  1. 03-03-2025Appointments: VANHEUSDEN Dirk Ferdinand (voorzitter van de…
  2. 05-07-2024Annual accounts filed
  3. 31-12-2023Highest result from 2018 to 2025
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
27-11-1989
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
8
Annual meeting
First Friday of June at 19:00
Purpose
“De exploitatie,huur en verhuur van één of meer apotheken; Het verzorgen van vervangingen…” (deed in Dutch)
Go to Articles of association

Key facts about Apotheek Vanheusden

What is the company number of Apotheek Vanheusden?
0439.111.575. In Belgium the VAT number is the company number with BE in front: BE 0439.111.575.
Where is Apotheek Vanheusden based?
The registered office is at Markt 12, 3740 Bilzen-Hoeselt.Company details
What does Apotheek Vanheusden do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Vanheusden?
Public limited company (NV).
When was Apotheek Vanheusden founded?
On 27-11-1989.
Is Apotheek Vanheusden still active?
Yes, Apotheek Vanheusden is an active enterprise in the KBO register.
How many employees does Apotheek Vanheusden have?
On average 1.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Vanheusden?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Vanheusden profitable?
In financial year 2025, Apotheek Vanheusden made a profit of €391,389.
Where can I find the annual accounts of Apotheek Vanheusden?
Apotheek Vanheusden filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Vanheusden due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Vanheusden

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.